Mike McDonald, chief executive of Oxford Biomedica, is to leave after one month in the job, as the company reduced its half-year losses.

Oxford Biomedica said Mr McDonald's departure was due to differences about strategy. He will be replaced temporarily by John Dawson, a non-executive director.